COMMUNIQUÉS West-GlobeNewswire

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
06/08/2026
Newly Allowed Patent Protects Cell-Free MyeloCelz™ Exosome Technology Designed to Suppress Autoimmune Destruction of Insulin-Producing Cells, Reinforcing Creative Medical's Multi-Program Diabetes Strategy PHOENIX, Aug. [...]
Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026
06/08/2026
SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world [...]
Spirited Paw® Healthy Mind By Standard Process® Named 2026 Senior Dog Nutrition Product of the Year
06/08/2026
The award recognizes Standard Process’ science-informed, whole food-based approach to supporting cognitive health in senior dogs PALMYRA, Wis., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Standard Process ® , a leader in whole [...]
Sonablate Announces Landmark Global Strategic Alliance with Eleven Ventures to Advance AI-Powered Precision Medicine
06/08/2026
Agreement establishes long-term commitment to support global expansion of Sonablate’s therapeutic ultrasound technology and facilitate up to $200 million in strategic capital formation JEDDAH, Saudi Arabia and CHARLOTTE [...]
Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside
06/08/2026
August 6, 2026 New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from admission through recovery at home Amsterdam, Netherlands. – Royal [...]
Alpha Pro Tech, Ltd. Announces Second Quarter 2026 Financial Results
06/08/2026
Second Quarter Net Sales Increased by 12% to $18.7 Million from $16.7 Million in the Second Quarter of 2025; Second Quarter Net Income Increased by 47% to $1.8 Million from $1.2 Million in the Prior Year Period Net [...]
Kyntra Bio to Report Second Quarter 2026 Financial Results
06/08/2026
SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio, Inc. (Nasdaq: KYNB) will announce second quarter 2026 financial results on Thursday, August 13 after market close. Kyntra Bio will also conduct a conference [...]
Sharecare launches AskMD nationwide to turn any health question into a personalized plan
06/08/2026
ATLANTA, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sharecare today announced that AskMD, its AI-powered health navigation experience grounded in each individual’s medical history, health plan, and location, is now available [...]
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
06/08/2026
Collaboration supports development of a next-generation AWS-native platform designed to accelerate commercialization, scalability and enterprise adoption SARASOTA, FLA., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma ( [...]
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
06/08/2026
ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that [...]
Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026
06/08/2026
ISELIN, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) [...]
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
06/08/2026
DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure [...]
Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call
06/08/2026
MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid [...]
Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology
06/08/2026
People with AAE-C1INH experience frequent misdiagnoses, emergency medical events, and wide-ranging impact on physical, emotional, and social well-being Study results informed the design and endpoint selection of the [...]
Zelluna ASA: Disclosure of large shareholding
06/08/2026
Reference is made to the stock exchange announcement published by Zelluna ASA (the "Company") on 4 August 2026 regarding the issuance of 446,752 new shares to Inven2 AS. Birk Venture AS currently holds 1,488,507 shares [...]
Enovis Announces Second Quarter 2026 Results
06/08/2026
Second-quarter sales growth of 3% on a reported basis, 5% organic Second-quarter Reconstructive sales grew 8% on a reported basis, 6% organic Reaffirmed full-year 2026 guidance for revenue, adjusted EBITDA, adjusted EPS [...]
Shape Therapeutics and Rett Syndrome Research Trust Announce Partnership to Advance a One-Time AI-Designed RNA Editing Therapy for Rett Syndrome
06/08/2026
Collaboration will evaluate Shape's intravenously delivered RNAfix ® gene therapy designed to correct the MECP2 R168X mutation in non-human primates (NHP) SEATTLE, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Shape Therapeutics, a [...]
Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
06/08/2026
2Q’26 Net Income of $9.0M, +236.7% from 2Q’25 2Q’26 Adjusted EBITDA of $37.4M, +29.1% from 2Q’25 Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Privia [...]
LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook
06/08/2026
Announces $100 Million Share Repurchase Program SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, [...]

Pages